DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
9.61
-0.38 (-3.80%)
Nov 18, 2026, 1:31 PM EST - Market open
DBV Technologies Employees
DBV Technologies had 179 employees as of September 30, 2026. The number of employees increased by 62 or 52.99% compared to the same quarter last year.
Employees
179
Change (1Y)
62
Growth (1Y)
52.99%
Revenue / Employee
$20,872
Profits / Employee
-$1,158,363
Market Cap
579.98M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2026 | 179 | 62 | 52.99% | 179 | 0 |
| Jun 30, 2026 | 170 | 61 | 55.96% | 170 | 0 |
| Mar 31, 2026 | 161 | 55 | 51.89% | 161 | 0 |
| Dec 31, 2025 | 126 | 16 | 14.55% | 125 | 1 |
| Sep 30, 2025 | 117 | 9 | 8.33% | 117 | 0 |
| Jun 30, 2025 | 109 | 3 | 2.83% | 109 | 0 |
| Mar 31, 2025 | 106 | 1 | 0.95% | 106 | 0 |
| Dec 31, 2024 | 110 | 5 | 4.76% | 109 | 1 |
| Sep 30, 2024 | 108 | 11 | 11.34% | 108 | 0 |
| Jun 30, 2024 | 106 | 18 | 20.45% | 106 | 0 |
| Mar 31, 2024 | 105 | 17 | 19.32% | 105 | 0 |
| Dec 31, 2023 | 105 | 19 | 22.09% | 104 | 1 |
| Sep 30, 2023 | 97 | 12 | 14.12% | 97 | 0 |
| Jun 30, 2023 | 88 | 1 | 1.15% | 88 | 0 |
| Mar 31, 2023 | 88 | 0 | - | 88 | 0 |
| Dec 31, 2022 | 86 | -6 | -6.52% | 85 | 1 |
| Sep 30, 2022 | 85 | -7 | -7.61% | 85 | 0 |
| Jun 30, 2022 | 87 | -10 | -10.31% | 87 | 0 |
| Mar 31, 2022 | 88 | -16 | -15.38% | 88 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Geron | 258 |
| Alumis | 253 |
| 4D Molecular Therapeutics | 196 |
| Olema Oncology | 150 |
| Janux Therapeutics | 114 |
| Adlai Nortye Group | 109 |
| Cullinan Therapeutics | 109 |
| Bicara Therapeutics | 103 |
DBVT News
- 6 days ago - DBV Technologies highlights data from VITESSE Phase 3 study of VIASKIN - TheFly
- 9 days ago - DBV Technologies Prepares Peanut Patch Launch as FDA Filing Decision Nears - MarketBeat
- 9 days ago - DBV Technologies Prepares Peanut Patch Launch as FDA Filing Decision Nears - Nasdaq
- 9 days ago - DBV Technologies Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 15 days ago - DBV Technologies to Participate in Upcoming November Investor Conferences - GlobeNewsWire
- 19 days ago - DBV Technologies price target lowered to $46 from $51 at Guggenheim - TheFly
- 20 days ago - DBV sinks after warning cash not sufficient to fund operations - TheFly
- 20 days ago - DBV Technologies price target lowered to $47 from $55 at Citizens - TheFly